The MR-Base platform supports systematic causal inference across the human phenome
暂无分享,去创建一个
Valeriia Haberland | Jack Bowden | Tom R. Gaunt | Stephen Burgess | Jie Zheng | Nicholas J Timpson | Tom R Gaunt | Richard M Martin | David M Evans | Hashem A. Shihab | Denis Baird | Gibran Hemani | Benjamin Elsworth | Kaitlin H Wade | Charles Laurin | Ryan Langdon | Vanessa Y Tan | James Yarmolinsky | Hashem A Shihab | Caroline Relton | George Davey Smith | Philip C Haycock | David M. Evans | N. Timpson | G. Davey Smith | J. Bowden | G. Hemani | S. Burgess | P. Haycock | C. Relton | Richard M. Martin | B. Elsworth | K. Wade | Jie Zheng | J. Yarmolinsky | R. Langdon | C. Laurin | V. Tan | Valeriia Haberland | D. Baird | Ryan J. Langdon | Vanessa Y. Tan | David M. Evans | David M. Evans | Charles Laurin
[1] Eric J Tchetgen Tchetgen,et al. Methodological Challenges in Mendelian Randomization , 2014, Epidemiology.
[2] N. Sheehan,et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic , 2016, International journal of epidemiology.
[3] Tanya M. Teslovich,et al. Common variants associated with plasma triglycerides and risk for coronary artery disease , 2013, Nature Genetics.
[4] Norbert Schuff,et al. Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits , 2016, Scientific Reports.
[5] J. Ioannidis,et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials , 2011, BMJ : British Medical Journal.
[6] Peggy Hall,et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..
[7] Tanya M. Teslovich,et al. Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.
[8] Dylan S. Small,et al. Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score , 2018, The Annals of Statistics.
[9] A. Price,et al. Dissecting the genetics of complex traits using summary association statistics , 2016, Nature Reviews Genetics.
[10] J. Danesh,et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .
[11] Joseph K. Pickrell,et al. Detection and interpretation of shared genetic influences on 42 human traits , 2015, Nature Genetics.
[12] S. Humphries,et al. Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes. , 2016, JAMA cardiology.
[13] P. Visscher,et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.
[14] Dylan S. Small,et al. Instrumental Variables Estimation With Some Invalid Instruments and its Application to Mendelian Randomization , 2014, 1401.5755.
[15] G. Davey Smith,et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies1 , 2016, The American journal of clinical nutrition.
[16] Jack Bowden,et al. Improving the visualisation, interpretation and analysis of two-sample summary data Mendelian randomization via the radial plot and radial regression , 2017, bioRxiv.
[17] Tom R. Gaunt,et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.
[18] Mario Roederer,et al. The Genetic Architecture of the Human Immune System: A Bioresource for Autoimmunity and Disease Pathogenesis , 2015, Cell.
[19] Yasuo Ohashi,et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials , 2010, The Lancet.
[20] T. Lehtimäki,et al. Integrative approaches for large-scale transcriptome-wide association studies , 2015, Nature Genetics.
[21] Donal N. Gorman,et al. Using Multivariable Mendelian Randomization to Disentangle the Causal Effects of Lipid Fractions , 2014, PloS one.
[22] Jack Bowden,et al. Unbiased estimation of odds ratios: combining genomewide association scans with replication studies , 2009, Genetic epidemiology.
[23] Tom R. Gaunt,et al. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study , 2017 .
[24] Fernando Pires Hartwig,et al. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption , 2017, bioRxiv.
[25] Olena O Yavorska,et al. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data , 2017, International journal of epidemiology.
[26] Stephen Burgess,et al. PhenoScanner: a database of human genotype–phenotype associations , 2016, Bioinform..
[27] George Davey Smith,et al. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.
[28] P. Visscher,et al. 10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.
[29] N. Sheehan,et al. A framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomization , 2017, Statistics in medicine.
[30] G. Davey Smith,et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.
[31] G. Davey Smith,et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.
[32] N. Timpson,et al. MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization , 2015, Scientific Reports.
[33] Joshua D. Angrist,et al. Split-Sample Instrumental Variables Estimates of the Return to Schooling , 1995 .
[34] Pak Chung Sham,et al. GWASdb v2: an update database for human genetic variants identified by genome-wide association studies , 2015, Nucleic Acids Res..
[35] P. Sham,et al. GWASdb v 2 : an update database for human genetic variants identified by genome-wide association studies , 2015 .
[36] G. Davey Smith,et al. Epidemiology--is it time to call it a day? , 2001, International journal of epidemiology.
[37] Matti Pirinen,et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies , 2015, bioRxiv.
[38] Tom R. Gaunt,et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis , 2016, bioRxiv.
[39] Andres Metspalu,et al. Genome-Wide Association Analyses in 128,266 Individuals Identifies New Morningness and Sleep Duration Loci , 2016, PLoS genetics.
[40] Brian A Ference,et al. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. , 2016, JAMA.
[41] Jon White,et al. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies , 2016, International journal of epidemiology.
[42] F. Dudbridge. Power and Predictive Accuracy of Polygenic Risk Scores , 2013, PLoS genetics.
[43] P. Visscher,et al. Five years of GWAS discovery. , 2012, American journal of human genetics.
[44] Jack Euesden,et al. PRSice: Polygenic Risk Score software , 2014, Bioinform..
[45] J. Angrist,et al. Estimating the Payoff to Schooling Using the Vietnam-Era Draft Lottery , 1991 .
[46] F. Hartwig,et al. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique , 2016, International journal of epidemiology.
[47] George Davey Smith,et al. Recent Developments in Mendelian Randomization Studies , 2017, Current Epidemiology Reports.
[48] Debbie A Lawlor,et al. Triangulation in aetiological epidemiology , 2016, International journal of epidemiology.
[49] M. Pirinen,et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA , 2016, Nature Communications.
[50] Tom R. Gaunt,et al. Systematic identification of genetic influences on methylation across the human life course , 2016, Genome Biology.
[51] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[52] G. Moneta,et al. Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .
[53] E. Birney,et al. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt , 2009, Nature Protocols.
[54] Anna Murray,et al. Variants in the FTO and CDKAL1 loci have recessive effects on risk of obesity and type 2 diabetes, respectively , 2015, bioRxiv.
[55] M. Daly,et al. An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.
[56] C. Wallace,et al. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.
[57] Sylvia Richardson,et al. JAM: A Scalable Bayesian Framework for Joint Analysis of Marginal SNP Effects , 2016, Genetic epidemiology.
[58] M. Munafo,et al. Robust research needs many lines of evidence , 2018, Nature.
[59] Tom R. Gaunt,et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis , 2016 .
[60] J. Pritchard,et al. Overcoming the winner's curse: estimating penetrance parameters from case-control data. , 2007, American journal of human genetics.
[61] S. Thompson,et al. Avoiding bias from weak instruments in Mendelian randomization studies. , 2011, International journal of epidemiology.
[62] Tom R. Gaunt,et al. Mendelian Randomization Analysis Identifies CpG Sites as Putative Mediators for Genetic Influences on Cardiovascular Disease Risk , 2017, American journal of human genetics.
[63] Tom R. Gaunt,et al. Automating Mendelian randomization through machine learning to construct a putative causal map of the human phenome , 2017, bioRxiv.
[64] G. Smith,et al. Mendelian randomization in cardiometabolic disease: challenges in evaluating causality , 2017, Nature Reviews Cardiology.
[65] Tetsuro Ohmori,et al. Retraction: A significant causal association between C-reactive protein levels and schizophrenia , 2018, Scientific Reports.
[66] B. Horta,et al. Inflammatory Biomarkers and Risk of Schizophrenia , 2017, JAMA psychiatry.
[67] P. Donnelly,et al. Genome-wide genetic data on ~500,000 UK Biobank participants , 2017, bioRxiv.
[68] John P. Overington,et al. An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.
[69] G. Davey Smith,et al. Orienting the causal relationship between imprecisely measured traits using GWAS summary data , 2017, PLoS genetics.
[70] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[71] G. Davey Smith,et al. Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.
[72] Jun S. Liu,et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.
[73] Luigi Ferrucci,et al. Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participants , 2016, bioRxiv.
[74] Marylyn D. Ritchie,et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations , 2010, Bioinform..
[75] M. O’Donovan,et al. Pleiotropic effects of trait-associated genetic variation on DNA methylation: utility for refining , 2018 .
[76] B. Neale,et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.
[77] Neil M Davies,et al. Software Application Profile: PHESANT: a tool for performing automated phenome scans in UK Biobank , 2017, International journal of epidemiology.
[78] J. Thompson,et al. Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors , 2016, Journal of clinical epidemiology.
[79] A. Brookes,et al. GWAS Central: a comprehensive resource for the comparison and interrogation of genome-wide association studies , 2013, European Journal of Human Genetics.
[80] B. Pierce,et al. Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators , 2013, American journal of epidemiology.
[81] Hynek Pikhart,et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.
[82] Hynek Pikhart,et al. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study , 2017, The lancet. Diabetes & endocrinology.